diagnostic imaging system News
-
Mevion Selected to Equip Proton Therapy Center at Tongji Hospital in China
Mevion Medical Systems today announced it has been selected by Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology to equip their new proton therapy center with a MEVION S250i Proton Therapy System® in Wuhan, China. The system at Tongji Hospital will feature Mevion’s industry leading HYPERSCAN® Pencil Beam Scanning (PBS) technology, ...
-
FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR
Dr. Roberto Diletti from The Erasmus Center in Rotterdam, Netherlands, presented the results of the two-year follow-up analysis of the FFR-SEARCH observational registry during the EuroPCR conference in Paris. The analysis evaluated the outcomes of patients and prognostic value of post-percutaneous coronary intervention (post-PCI) FFR assessment, indicating patients with a lower FFR post-PCI ...
-
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of Oncology
Kheiron Medical Technologies today announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning models to solve clinical problems in novel ways, starting with Non-Hodgkin’s Lymphoma (NHL). With the collaboration, Kheiron, which has pioneered the development and deployment of artificial intelligence solutions to help radiologists ...
-
Invenio Imaging receives CE Mark for NIO Laser Imaging System
SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD). This enables commercialization of this novel imaging system for intraoperative histology in the European market. The NIO Laser Imaging System uses Stimulated Raman Histology to ...
-
Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure
Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health care company in the Blue Cross Blue Shield Association, has provided positive payer coverage for the Sonata® Treatment. Anthem’s decision creates ...
By Gynesonics
-
Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the state of Texas to offer its Sonata® Treatment to women with symptomatic uterine fibroids as an office-based procedure at his River Place ...
By Gynesonics
-
Gynesonics Announces Positive Payer Coverage Issued by Blue Cross Blue Shield of Florida (Florida Blue) for the Sonata Treatment
Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has released a coverage policy for its Sonata® Procedure.1 The addition of the Florida Blue policy allows another 5 million covered lives in ...
By Gynesonics
-
Gynesonics Announces FDA Clearance of Next Generation Sonata System
Redwood City, CA, September 16, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the Food and Drug Administration (FDA) has given clearance of the Sonata® System 2.2 which provides important new benefits for facilities, physicians and patients. These benefits include: ...
By Gynesonics
-
Gynesonics Announces Positive Coverage Policy Decision Published by Cigna for Treatment of Uterine Fibroids with the Sonata System
Redwood City, CA, June 3, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage policy for treatment of uterine fibroids with the Sonata® System.1 Cigna is one of the largest commercial payers in the country with a significant ...
By Gynesonics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you